Fingerprint
Dive into the research topics of 'Final analysis of a phase II trial using sorafenib for metastaticcastration-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Final analysis of a phase II trial using sorafenib for metastaticcastration-resistant prostate cancer
Jeanny B. Aragon-Ching, Lokesh Jain, James L. Gulley, Philip M. Arlen, John J. Wright, Seth M. Steinberg, David Draper, Jürgen Venitz, Elizabeth Jones, Clara C. Chen, William D. Figg, William L. Dahut
Research output: Contribution to journal › Article › peer-review
110
Scopus
citations